Education
About Us
Working with TipRanks
Follow Us
XT - ETF AI Analysis
Top Page
iShares Exponential Technologies ETF (XT)
Rating:63Neutral
Price Target:
$79.00
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, including Nvidia and Broadcom, have delivered strong year-to-date performance, boosting overall returns.
Sector Diversification
The fund is spread across multiple sectors, with significant exposure to Technology and Health Care, reducing reliance on a single industry.
Healthy Performance
The ETF has shown steady gains year-to-date and over the past three months, indicating strong momentum.
Negative Factors
High Technology Exposure
With over 42% of the portfolio in Technology, the fund is heavily reliant on the sector, which could be risky during downturns.
Underperforming Holdings
Some top holdings, like Texas Instruments and Eli Lilly, have lagged in performance, potentially dragging on overall returns.
Limited Global Diversification
The ETF is predominantly focused on U.S. companies, with over 63% exposure, offering less protection against international market opportunities.
XT vs. SPDR S&P 500 ETF (SPY)
AUM3.58B
RegionGlobal
Expense Ratio0.46%
Beta1.09
IssueriShares
Inception DateMar 19, 2015
Dividend Yield0.63%
Asset ClassEquity
Index TrackedMorningstar Exponential Technologies Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume114,732
30 Day Avg. Volume112,385
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
83.33Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering268
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XT Summary
The iShares Exponential Technologies ETF (XT) is an investment fund that focuses on companies driving innovation in fields like robotics, artificial intelligence, and bioinformatics. It follows the Morningstar Exponential Technologies Index and includes well-known companies such as Tesla and Nvidia. This ETF is ideal for investors looking to benefit from the growth potential of cutting-edge technologies while gaining exposure to a diverse range of industries. However, new investors should be aware that XT’s performance can be heavily influenced by the tech sector, which tends to experience significant ups and downs.
How much will it cost me?The iShares Exponential Technologies ETF (XT) has an expense ratio of 0.46%, meaning you’ll pay $4.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed to focus on innovative and emerging technologies, which require more research and specialized expertise.
What would affect this ETF?The iShares Exponential Technologies ETF (XT) could benefit from continued advancements in technology, such as artificial intelligence and robotics, which are driving innovation across industries globally. However, it may face challenges from rising interest rates, which can impact growth-focused companies, and potential regulatory changes affecting key sectors like healthcare and technology. Its global exposure and diversified holdings provide resilience, but economic slowdowns or geopolitical tensions could negatively affect its performance.
XT Top 10 Holdings
The iShares Exponential Technologies ETF (XT) is riding the wave of innovation, with Nvidia and Broadcom leading the charge thanks to their strong positioning in AI and semiconductor technologies. Microsoft and Eli Lilly are steady contributors, benefiting from growth in cloud services and healthcare advancements, respectively. However, Tesla’s high valuation risks and Texas Instruments’ recent struggles in the automotive market are holding back performance. With a heavy tilt toward technology and healthcare sectors and a global reach, XT offers a dynamic mix of rising stars and a few lagging players in the race for exponential growth.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 2.94% | $102.59M | $992.27B | 39.12% | 76 Outperform | |
| Tesla | 2.46% | $85.75M | $1.34T | 16.37% | 73 Outperform | |
| Nvidia | 2.43% | $84.69M | $4.53T | 23.16% | 76 Outperform | |
| Microsoft | 2.14% | $74.83M | $3.62T | 15.88% | 82 Outperform | |
| Amazon | 1.80% | $62.77M | $2.38T | 9.46% | 71 Outperform | |
| Texas Instruments | 1.74% | $60.54M | $142.74B | -22.64% | 68 Neutral | |
| AbbVie | 1.60% | $55.92M | $411.64B | 33.61% | 62 Neutral | |
| Johnson & Johnson | 1.55% | $54.15M | $487.91B | 30.59% | 78 Outperform | |
| Alphabet Class A | 1.50% | $52.18M | $3.53T | 72.67% | 80 Outperform | |
| Broadcom | 1.44% | $50.28M | $1.67T | 111.55% | 76 Outperform |
XT Technical Analysis
Neutral
―
Price Trends
73.03
Negative
69.97
Positive
65.01
Positive
Market Momentum
-0.26
Positive
33.80
Neutral
10.69
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XT, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 74.13, equal to the 50-day MA of 73.03, and equal to the 200-day MA of 65.01, indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 33.80 is Neutral, neither overbought nor oversold. The STOCH value of 10.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for XT.
XT Peer Comparison
Comparison Results
Performance Comparison
XT
iShares Exponential Technologies ETF
70.59
10.20
16.89%
IGF
iShares Global Infrastructure ETF
―
―
―
BAI
iShares A.I. Innovation and Tech Active ETF
―
―
―
ARKK
Ark Innovation Etf
―
―
―
GUNR
FlexShares Morningstar Global Upstream Natural Resources Index Fund
―
―
―
GRID
First Trust Nasdaq Clean Edge Smart GRID Infrastructure Index
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents